These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 33887222
1. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis. Tan A, Li T, Ruan L, Yang J, Luo Y, Li L, Wu X. Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222 [Abstract] [Full Text] [Related]
2. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Liu P, Jia SB, Shi JM, Li WJ, Tang LS, Zhu XH, Tong P. Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30988072 [Abstract] [Full Text] [Related]
3. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p. Yu L, Fu J, Yu N, Wu Y, Han N. Can J Physiol Pharmacol; 2020 Apr 31; 98(4):219-227. PubMed ID: 31689123 [Abstract] [Full Text] [Related]
4. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Zou J, Liu KC, Wang WP, Xu Y. Life Sci; 2020 Sep 01; 256():117888. PubMed ID: 32497630 [Abstract] [Full Text] [Related]
6. Downregulation of circ-UBAP2 ameliorates oxidative stress and dysfunctions of human retinal microvascular endothelial cells (hRMECs) via miR-589-5p/EGR1 axis. Jiewei Y, Jingjing Z, Jingjing X, Guilan Z. Bioengineered; 2021 Dec 01; 12(1):7508-7518. PubMed ID: 34608841 [Abstract] [Full Text] [Related]
10. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy. Han N, Tian W, Yu N, Yu L. J Cell Physiol; 2020 Feb 01; 235(2):1309-1320. PubMed ID: 31313295 [Abstract] [Full Text] [Related]
16. The mechanism by which crocetin regulates the lncRNA NEAT1/miR-125b-5p/SOX7 molecular axis to inhibit high glucose-induced diabetic retinopathy. Chen Q, Xi X, Ma J, Wang X, Xia Y, Wang X, Deng Y, Li Y. Exp Eye Res; 2022 Sep 01; 222():109157. PubMed ID: 35718188 [Abstract] [Full Text] [Related]